IL146731A0 - Factor viia inhibitors - Google Patents
Factor viia inhibitorsInfo
- Publication number
- IL146731A0 IL146731A0 IL14673100A IL14673100A IL146731A0 IL 146731 A0 IL146731 A0 IL 146731A0 IL 14673100 A IL14673100 A IL 14673100A IL 14673100 A IL14673100 A IL 14673100A IL 146731 A0 IL146731 A0 IL 146731A0
- Authority
- IL
- Israel
- Prior art keywords
- factor viia
- viia inhibitors
- inhibitors
- factor
- viia
- Prior art date
Links
- 229940082863 Factor VIIa inhibitor Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99111109A EP1059302A1 (en) | 1999-06-08 | 1999-06-08 | Factor VIIa inhibitors |
| PCT/EP2000/004846 WO2000075172A2 (en) | 1999-06-08 | 2000-05-27 | FACTOR VIIa INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL146731A0 true IL146731A0 (en) | 2002-07-25 |
Family
ID=8238315
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14673100A IL146731A0 (en) | 1999-06-08 | 2000-05-27 | Factor viia inhibitors |
| IL146731A IL146731A (en) | 1999-06-08 | 2001-11-25 | Factor VIIa inhibitors |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL146731A IL146731A (en) | 1999-06-08 | 2001-11-25 | Factor VIIa inhibitors |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6500803B1 (cs) |
| EP (2) | EP1059302A1 (cs) |
| JP (1) | JP4546683B2 (cs) |
| KR (1) | KR100979069B1 (cs) |
| CN (1) | CN1359390B (cs) |
| AR (1) | AR024292A1 (cs) |
| AT (1) | ATE246707T1 (cs) |
| AU (1) | AU774037B2 (cs) |
| BR (1) | BR0011461A (cs) |
| CA (1) | CA2376064C (cs) |
| CZ (1) | CZ300365B6 (cs) |
| DE (1) | DE60004363T2 (cs) |
| DK (1) | DK1189929T3 (cs) |
| EE (1) | EE04855B1 (cs) |
| ES (1) | ES2202137T3 (cs) |
| HK (1) | HK1047289B (cs) |
| HR (1) | HRP20010912B1 (cs) |
| HU (1) | HUP0201451A3 (cs) |
| IL (2) | IL146731A0 (cs) |
| ME (1) | MEP57708A (cs) |
| MX (1) | MXPA01012568A (cs) |
| NO (1) | NO328249B1 (cs) |
| NZ (1) | NZ515966A (cs) |
| PL (1) | PL202879B1 (cs) |
| PT (1) | PT1189929E (cs) |
| RS (1) | RS50415B (cs) |
| RU (1) | RU2248359C2 (cs) |
| SI (1) | SI1189929T1 (cs) |
| SK (1) | SK286902B6 (cs) |
| TR (1) | TR200103550T2 (cs) |
| WO (1) | WO2000075172A2 (cs) |
| ZA (1) | ZA200110053B (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1059302A1 (en) * | 1999-06-08 | 2000-12-13 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitors |
| DE10005631A1 (de) * | 2000-02-09 | 2001-08-23 | Max Planck Gesellschaft | Arginin-Mimetika als Faktor X¶a¶-Inhibitoren |
| GB0014134D0 (en) * | 2000-06-10 | 2000-08-02 | Astrazeneca Ab | Combination therapy |
| EP1364960A4 (en) * | 2001-02-02 | 2005-05-18 | Chugai Pharmaceutical Co Ltd | PEPTIDE DERIVATIVES |
| GB0127615D0 (en) * | 2001-07-09 | 2002-01-09 | Aventis Pharm Prod Inc | Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| JP5043429B2 (ja) * | 2003-08-18 | 2012-10-10 | ハー・ルンドベック・アクチエゼルスカベット | トランス−４−（（１ｒ，３ｓ）−６−クロロ−３−フェニルインダン−１−イル）−１，２，２−トリメチルピペラジンのコハク酸塩およびマロン酸塩、および薬剤としての使用方法 |
| TWI453198B (zh) | 2005-02-16 | 2014-09-21 | Lundbeck & Co As H | 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s）-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法 |
| TWI376373B (en) | 2005-02-16 | 2012-11-11 | Lundbeck & Co As H | Crystalline base of a pharmaceutical compound |
| ES2337831T3 (es) * | 2005-06-24 | 2010-04-29 | Bristol-Myers Squibb Company | Derivados de fenilglicinamida y piridilclicinamida utiles como agentes anticoagulantes. |
| WO2007131996A1 (en) * | 2006-05-12 | 2007-11-22 | Genmedica Therapeutics Sl | Meta-xylylenediamine vanadate salts |
| US11021514B2 (en) | 2016-06-01 | 2021-06-01 | Athira Pharma, Inc. | Compounds |
| DK3993876T3 (en) | 2019-07-01 | 2024-12-02 | Tonix Pharma Ltd | Anti-cd154 antibodies and uses thereof |
| EP4274587A1 (en) | 2021-01-06 | 2023-11-15 | Tonix Pharma Limited | Methods of inducing immune tolerance with modified anti-cd154 antibodies |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023236A (en) * | 1988-04-07 | 1991-06-11 | Corvas, Inc. | Factor VII/VIIA active site inhibitors |
| US5506134A (en) | 1990-10-22 | 1996-04-09 | Corvas International, Inc. | Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
| US5788965A (en) | 1991-02-28 | 1998-08-04 | Novo Nordisk A/S | Modified factor VII |
| US5833982A (en) | 1991-02-28 | 1998-11-10 | Zymogenetics, Inc. | Modified factor VII |
| DE4115468A1 (de) * | 1991-05-11 | 1992-11-12 | Behringwerke Ag | Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien |
| SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
| SI9520044B (sl) * | 1994-04-26 | 2004-08-31 | Aventis Pharmaceuticals Inc. | Inhibitorji Xa faktorja |
| PT892780E (pt) * | 1996-02-22 | 2003-02-28 | Bristol Myers Squibb Pharma Co | Analogos de m-amidino fenilo como inibidores do factor xa |
| AR013084A1 (es) * | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
| EP0987274A1 (en) * | 1998-09-15 | 2000-03-22 | Hoechst Marion Roussel Deutschland GmbH | Factor VIIa Inhibitors |
| EP1059302A1 (en) * | 1999-06-08 | 2000-12-13 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitors |
-
1999
- 1999-06-08 EP EP99111109A patent/EP1059302A1/en not_active Withdrawn
-
2000
- 2000-05-27 IL IL14673100A patent/IL146731A0/xx active IP Right Grant
- 2000-05-27 RS YUP-861/01A patent/RS50415B/sr unknown
- 2000-05-27 PL PL352200A patent/PL202879B1/pl not_active IP Right Cessation
- 2000-05-27 JP JP2001502453A patent/JP4546683B2/ja not_active Expired - Fee Related
- 2000-05-27 CN CN008098131A patent/CN1359390B/zh not_active Expired - Fee Related
- 2000-05-27 EP EP00938691A patent/EP1189929B1/en not_active Expired - Lifetime
- 2000-05-27 HR HR20010912A patent/HRP20010912B1/xx not_active IP Right Cessation
- 2000-05-27 SK SK1759-2001A patent/SK286902B6/sk not_active IP Right Cessation
- 2000-05-27 NZ NZ515966A patent/NZ515966A/en not_active IP Right Cessation
- 2000-05-27 MX MXPA01012568A patent/MXPA01012568A/es active IP Right Grant
- 2000-05-27 DK DK00938691T patent/DK1189929T3/da active
- 2000-05-27 PT PT00938691T patent/PT1189929E/pt unknown
- 2000-05-27 SI SI200030222T patent/SI1189929T1/xx unknown
- 2000-05-27 BR BR0011461-8A patent/BR0011461A/pt active Search and Examination
- 2000-05-27 HU HU0201451A patent/HUP0201451A3/hu unknown
- 2000-05-27 DE DE60004363T patent/DE60004363T2/de not_active Expired - Lifetime
- 2000-05-27 EE EEP200100662A patent/EE04855B1/xx not_active IP Right Cessation
- 2000-05-27 AU AU53976/00A patent/AU774037B2/en not_active Ceased
- 2000-05-27 RU RU2002100067/04A patent/RU2248359C2/ru not_active IP Right Cessation
- 2000-05-27 ME MEP-577/08A patent/MEP57708A/xx unknown
- 2000-05-27 ES ES00938691T patent/ES2202137T3/es not_active Expired - Lifetime
- 2000-05-27 HK HK02108635.2A patent/HK1047289B/zh not_active IP Right Cessation
- 2000-05-27 CA CA2376064A patent/CA2376064C/en not_active Expired - Fee Related
- 2000-05-27 TR TR2001/03550T patent/TR200103550T2/xx unknown
- 2000-05-27 CZ CZ20014357A patent/CZ300365B6/cs not_active IP Right Cessation
- 2000-05-27 KR KR1020017015807A patent/KR100979069B1/ko not_active Expired - Fee Related
- 2000-05-27 WO PCT/EP2000/004846 patent/WO2000075172A2/en not_active Ceased
- 2000-05-27 AT AT00938691T patent/ATE246707T1/de active
- 2000-06-06 AR ARP000102796A patent/AR024292A1/es active IP Right Grant
- 2000-06-07 US US09/588,651 patent/US6500803B1/en not_active Expired - Lifetime
-
2001
- 2001-11-25 IL IL146731A patent/IL146731A/en not_active IP Right Cessation
- 2001-12-06 ZA ZA200110053A patent/ZA200110053B/xx unknown
- 2001-12-07 NO NO20016005A patent/NO328249B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL141415A0 (en) | Factor viia inhibitors | |
| GB9900416D0 (en) | Inhibitors | |
| ZA200306490B (en) | Inhibitors of factor Xa. | |
| IL137517A0 (en) | Substituted oxoazaheterocyclyl factor xa inhibitors | |
| IL148820A0 (en) | Fab i inhibitors | |
| ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
| GB2321641B (en) | Sulfamide-metalloprotease inhibitors | |
| HUP0201451A3 (en) | Factor viia inhibitors | |
| EP1153022A4 (en) | PROTEASE INHIBITORS | |
| PL350941A1 (en) | Pyrazole-3-on-derivative as factor xa inhibitors | |
| PL345574A1 (en) | Angiogenesis inhibitors | |
| AU2001283340A1 (en) | Factor viia inhibitors | |
| GB2389113B (en) | B-secretase inhibitor | |
| GB9900413D0 (en) | Inhibitors | |
| GB9929340D0 (en) | Inhibitors | |
| GB9917294D0 (en) | Inhibitors | |
| GB9929341D0 (en) | Inhibitors | |
| GB9828697D0 (en) | Inhibitors | |
| GB9826992D0 (en) | Inhibitors | |
| GB9803416D0 (en) | Inhibitors | |
| GB9913635D0 (en) | Modified surfaces | |
| GB0029733D0 (en) | Inhibitors | |
| GB0015996D0 (en) | Inhibitors | |
| GB0021193D0 (en) | Inhibitors | |
| GB0029730D0 (en) | Inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |